Paper26316699
Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
Zhou X and 9 others. Drug Des Devel Ther, 2015. Cited by 81 papers, by iCite.
Cite this record
ConductScience Library. Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway. Papers, record 26316699. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26316699
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiomyopathies | Major topic |
| Endothelial Cells | Major topic |
| Epithelial-Mesenchymal Transition | Major topic |
| Myocardium | Major topic |
| Receptor, Notch1 | Major topic |
| Relaxin | Major topic |
| Signal Transduction | Major topic |
| Animals | |
| Cell Movement | |
| Cells, Cultured | |
| Collagen | |
| Dipeptides | |
| Disease Models, Animal | |
| Fibrosis | |
| Human Umbilical Vein Endothelial Cells | |
| Humans | |
| Isoproterenol | |
| Male | |
| Neovascularization, Physiologic | |
| Rats, Sprague-Dawley | |
| Ventricular Function, Left |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 28435227 | Erratum: Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway [Corrigendum]. | https://conductscience.org/library/papers/28435227 |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23063463 | TGF-β signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities. | Cell Signal | 2013 | https://conductscience.org/library/papers/23063463 | PubMed |
| 2 | 21106947 | Origins of cardiac fibroblasts. | Circ Res | 2010 | https://conductscience.org/library/papers/21106947 | PubMed |
| 3 | 23471419 | Inflammatory stress exacerbates the progression of cardiac fibrosis in high-fat-fed apolipoprotein E knockout mice via endothelial-mesenchymal transition. | Int J Med Sci | 2013 | https://conductscience.org/library/papers/23471419 | PubMed |
| 4 | 23704950 | Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling. | PLoS One | 2013 | https://conductscience.org/library/papers/23704950 | PubMed |
| 5 | 23850080 | Notch signal regulates corneal endothelial-to-mesenchymal transition. | Am J Pathol | 2013 | https://conductscience.org/library/papers/23850080 | PubMed |
| 6 | 24937432 | Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. | J Clin Invest | 2014 | https://conductscience.org/library/papers/24937432 | PubMed |
| 7 | 23166366 | The Notch pathway controls fibrotic and regenerative repair in the adult heart. | Eur Heart J | 2014 | https://conductscience.org/library/papers/23166366 | PubMed |
| 8 | 25215881 | Foramen ovale closure is a process of endothelial-to-mesenchymal transition leading to fibrosis. | PLoS One | 2014 | https://conductscience.org/library/papers/25215881 | PubMed |
| 9 | 25342127 | Relaxin protects cardiac muscle cells from hypoxia/reoxygenation injury: involvement of the Notch-1 pathway. | FASEB J | 2015 | https://conductscience.org/library/papers/25342127 | PubMed |
| 10 | 11739020 | The vasorelaxant hormone relaxin induces changes in liver sinusoid microcirculation: a morphologic study in the rat. | J Endocrinol | 2001 | https://conductscience.org/library/papers/11739020 | PubMed |
| 11 | 12244553 | Characterization of Notch receptor expression in the developing mammalian heart and liver. | Am J Med Genet | 2002 | https://conductscience.org/library/papers/12244553 | PubMed |
| 12 | 12730128 | Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. | Circ Res | 2003 | https://conductscience.org/library/papers/12730128 | PubMed |
| 13 | 14701881 | Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. | Genes Dev | 2004 | https://conductscience.org/library/papers/14701881 | PubMed |
| 14 | 21221074 | Relaxin remodels fibrotic healing following myocardial infarction. | Lab Invest | 2011 | https://conductscience.org/library/papers/21221074 | PubMed |
| 15 | 21425122 | Protein kinase Cδ and c-Abl kinase are required for transforming growth factor β induction of endothelial-mesenchymal transition in vitro. | Arthritis Rheum | 2011 | https://conductscience.org/library/papers/21425122 | PubMed |
| 16 | 21839921 | Notch initiates the endothelial-to-mesenchymal transition in the atrioventricular canal through autocrine activation of soluble guanylyl cyclase. | Dev Cell | 2011 | https://conductscience.org/library/papers/21839921 | PubMed |
| 17 | 21763673 | Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. | Am J Pathol | 2011 | https://conductscience.org/library/papers/21763673 | PubMed |
| 18 | 22723165 | [Relationship between endothelial-to-mesenchymal transition and cardiac fibrosis in acute viral myocarditis]. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2012 | https://conductscience.org/library/papers/22723165 | PubMed |
| 19 | 22936987 | Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS. | PLoS One | 2012 | https://conductscience.org/library/papers/22936987 | PubMed |
| 20 | 22835547 | Relaxin induces matrix-metalloproteinases-9 and -13 via RXFP1: induction of MMP-9 involves the PI3K, ERK, Akt and PKC-ζ pathways. | Mol Cell Endocrinol | 2012 | https://conductscience.org/library/papers/22835547 | PubMed |
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41859765 | Notch signaling pathway and heart development, congenital heart disease, and myocardial regeneration. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/41859765 | PubMed |
| 40630953 | The role of notch signaling pathway in cancer: mechanistic insights, therapeutic potential, and clinical progress. | Front Immunol | 2025 | https://conductscience.org/library/papers/40630953 | PubMed |
| 40520009 | Heart failure, inflammation and exercise. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/40520009 | PubMed |
| 39989120 | Endothelial Cell Phenotypic Plasticity in Cardiovascular Physiology and Disease: Mechanisms and Therapeutic Prospects. | Am J Hypertens | 2025 | https://conductscience.org/library/papers/39989120 | PubMed |
| 39789529 | Broadening horizons: molecular mechanisms and disease implications of endothelial-to-mesenchymal transition. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/39789529 | PubMed |
| 39704307 | Relaxin Inhibits Angiotensin II-Induced Cardiac Fibrosis by Activating NO/cGMP Signaling Pathway. | Anatol J Cardiol | 2025 | https://conductscience.org/library/papers/39704307 | PubMed |
| 39200259 | Pathophysiology in Brain Arteriovenous Malformations: Focus on Endothelial Dysfunctions and Endothelial-to-Mesenchymal Transition. | Biomedicines | 2024 | https://conductscience.org/library/papers/39200259 | PubMed |
| 39062169 | Enhancing Neoadjuvant Virotherapy's Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer. | Biomedicines | 2024 | https://conductscience.org/library/papers/39062169 | PubMed |
| 37289083 | Porcine Deltacoronavirus Infection Disrupts the Intestinal Mucosal Barrier and Inhibits Intestinal Stem Cell Differentiation to Goblet Cells via the Notch Signaling Pathway. | J Virol | 2023 | https://conductscience.org/library/papers/37289083 | PubMed |
| 37176063 | Serelaxin Alleviates Fibrosis in Thyroid-Associated Ophthalmopathy via the Notch Pathway. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37176063 | PubMed |
| 37125076 | Proteomic analysis of transcription factors involved in the alteration of ischemic mouse heart as modulated by MSC exosomes. | Biochem Biophys Rep | 2023 | https://conductscience.org/library/papers/37125076 | PubMed |
| 36776449 | Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter]. | Drug Des Devel Ther | 2023 | https://conductscience.org/library/papers/36776449 | PubMed |
| 36570135 | Evaluation of pharmacological activities and active components in Tremella aurantialba by instrumental and virtual analyses. | Front Nutr | 2022 | https://conductscience.org/library/papers/36570135 | PubMed |
| 36465358 | TGF-β1 promotes human breast cancer angiogenesis and malignant behavior by regulating endothelial-mesenchymal transition. | Front Oncol | 2022 | https://conductscience.org/library/papers/36465358 | PubMed |
| 35783195 | The Role of Mitochondria in Metabolic Syndrome-Associated Cardiomyopathy. | Oxid Med Cell Longev | 2022 | https://conductscience.org/library/papers/35783195 | PubMed |
| 35754998 | Role of the Endothelium in Neonatal Diseases. | Newborn (Clarksville) | 2022 | https://conductscience.org/library/papers/35754998 | PubMed |
| 35694669 | Toward Human Models of Cardiorenal Syndrome in vitro. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35694669 | PubMed |
| 35266091 | Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction. | Heart Fail Rev | 2023 | https://conductscience.org/library/papers/35266091 | PubMed |
| 34266366 | A promising field: regulating imbalance of EndMT in cardiovascular diseases. | Cell Cycle | 2021 | https://conductscience.org/library/papers/34266366 | PubMed |
| 34244974 | Role of PI3K/Akt signaling pathway in cardiac fibrosis. | Mol Cell Biochem | 2021 | https://conductscience.org/library/papers/34244974 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| HES1 | 3280 | PubTator's text mining | https://conductscience.org/library/genes/3280 | NCBI Gene |
| JAG1 | 182 | PubTator's text mining | https://conductscience.org/library/genes/182 | NCBI Gene |
| NOTCH1 | 4851 | PubTator's text mining | https://conductscience.org/library/genes/4851 | NCBI Gene |
| PECAM1 | 5175 | PubTator's text mining | https://conductscience.org/library/genes/5175 | NCBI Gene |
| POTEF | 728378 | PubTator's text mining | https://conductscience.org/library/genes/728378 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| VIM | 7431 | PubTator's text mining | https://conductscience.org/library/genes/7431 | NCBI Gene |
| VWF | 7450 | PubTator's text mining | https://conductscience.org/library/genes/7450 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26316699
GET https://conductscience.org/api/papers/v1/26316699/references?page=2